|Target||activin receptor-like kinase 1|
Ascrinvacumab is a monoclonal antibody designed for the treatment of cancer.
This drug was developed by Pfizer Inc.
- Statement On A Nonproprietary Name Adopted By The USAN Council - Ascrinvacumab, American Medical Association.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.